
"I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products," Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said in a call with analysts.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2U6Jkgd
via
IFTTT
0 comments:
Post a Comment